Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery

Retrieved on: 2022-06-29 17:10:14

Tags for this article:

Click the tags to see associated articles and topics

Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery. View article details on hiswai:

Excerpt

In less than one year, ReCode Therapeutics has reeled in $200 million in financing. Big pharmaceutical companies are taking notice of the biotech ...

Article found on: medcitynews.com